Showing results (31-40 of 97) with videos related to
Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2010
Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantationCarlos A Ramos, Rima M Saliba, Leandro de Pádua Silva, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2017
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaAnkur Varma, Laura Biritxinaga, Rima M Saliba, et al.Bone Marrow Transplantation|April 13, 2021
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortalityJeremy L Ramdial, Rohtesh S Mehta, Rima M Saliba, et al.Cancer|June 19, 2013
Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remissionZaher I Chakhachiro, Rima M Saliba, Grace-Julia Okoroji, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 5, 2013
Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myelomaKoji Sasaki, Gary Lu, Rima M Saliba, et al.Leukemia|June 17, 2021
Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantationBetül Oran, Richard E Champlin, Feng Wang, et al.Bone Marrow Transplantation|October 20, 2018
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantationMithun Vinod Shah, Rima M Saliba, Gabriela Rondon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2008
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trialMuzaffar H Qazilbash, Rima M Saliba, Yago Nieto, et al.Pageof 10